Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.4"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 211.3;Syncytiotrophoblasts: 350.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 19.6;JURKAT: 20.6;OE19: 25.4;RPMI-8226: 29.2;U-937: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA					"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	6.1	4.8	22.8	8.6	26.6	16.3	9.1	17.1	19.6	9.0	14.0	21.8	9.7	28.1	8.5	12.3	7.5	10.8	12.4	32.4	26.3	9.2	19.5	5.5	10.8	13.4	15.1	20.4	12.3	28.8	9.3	5.7	66.4	21.3	14.8	12.5	9.9	21.8	10.2	19.5	9.3	25.9	8.0	11.1	16.1	26.9	21.6	22.9	11.9	14.9	4.8	12.2	8.7	7.1	7.2	4.4	8.7	6.3	12.6	5.5	2.7	0.0	4.7	1.4	0.0	4.5	1.7	0.1	0.5	2.0	2.0	1.4	4.7	0.6	8.2	0.8	1.9	8.8	2.4	6.9	1.0	0.4	0.0	0.6	14.1	0.1	19.6	4.6	3.3	0.1	2.9	3.5	0.2	0.0	0.0	4.4	20.6	0.7	15.8	0.1	0.5	19.0	5.6	0.1	25.4	7.6	14.9	0.4	29.2	3.0	3.7	3.4	0.1	0.9	1.9	13.1	0.1	9.1	7.5	0.6	0.0	0.0	0.0	0.2	11.0	0.7	0.0	0.2	20.3	5.2	6.3	3.7	8.7	5.5	6.3	4.5	5.2	3.7	4.8	4.4	7.2	3.2	4.9	0.8	12.6	4.1	2.8	3.2	2.7	22.8	26.6	17.1	19.6	26.3	9.2	15.1	20.4	21.3	22.9	11.9	13.7	25.6	6.7	4.6	2.4	60.2	45.9	9.4	9.1	10.4	0.0	211.3	64.6	3.4	72.5	7.1	29.0	23.3	6.7	6.5	11.6	9.5	5.7	5.0	43.5	0.0	0.0	9.2	7.5	14.5	31.9	8.1	6.8	2.8	28.5	14.3	3.0	14.0	30.4	14.0	0.7	19.4	14.4	0.9	1.1	3.8	350.8	23.5	21.3	3.0
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 98.3;Mucus-secreting cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	30.3	12.6	2.8	9.2	7.0	1.9	12.4	5.6	7.0	6.8	21.0	10.6	8.3	21.4	6.6	7.0	8.1	4.5	7.7	24.8	2.9	2.5	11.2	15.7	11.7	3.2	6.8	3.2	5.1	3.2	4.7	2.5	4.6	5.5	3.4	10.4	3.5	9.8	6.8	63.4	6.8	24.1	3.0	6.1	2.7	13.4	3.1	7.1	1.1	3.9	7.3	3.0	6.5	6.1	0.7	12.6	17.0	11.6	0.3	3.0	4.7	11.9	1.6	1.2	1.6	8.5	9.0	12.4	7.1	5.5	2.0	3.5	4.3	6.6	0.0	8.1	3.1	7.7	9.0	2.9	17.9	1.5	0.1	2.8	16.6	0.8	2.0	6.2	1.6	9.1	6.1	3.9	2.9	2.8	2.9	3.1	1.2	10.5	1.3	2.7	1.4	0.5	7.3	0.8	3.6	20.3	4.4	7.8	26.2	6.8	1.2	1.1	5.4	8.7	6.4	6.9	3.4	3.1	3.6	11.7	2.4	3.3	4.3	2.3	11.3	8.2	3.8	6.7	2.6	1.9	17.0	11.6	3.0	0.6	7.2	0.5	0.4	1.6	0.7	12.6	0.7	3.0	1.5	6.5	0.3	3.4	2.1	1.1	4.7	2.8	7.0	5.6	7.0	2.9	2.5	6.8	3.2	5.5	7.1	11.9	40.9	3.0	8.5	6.9	6.0	70.4	25.5	5.3	13.6	10.4	5.9	13.6	10.0	16.5	7.2	13.2	98.3	23.3	29.5	8.5	8.9	8.8	9.2	44.8	14.7	7.9	7.5	10.4	17.2	6.0	10.6	13.8	13.5	19.8	80.6	8.8	18.1	60.0	4.2	51.2	3.4	12.9	9.9	11.6	7.3	9.5	17.5	5.0	60.0	8.9
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261205	"Enzymes, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 42.8;Hepatocytes: 47.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 8.3;neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	19.6	18.3	7.4	1.9	8.3	1.0	8.1	2.7	7.7	13.2	2.6	5.5	10.8	1.2	18.2	14.4	2.0	8.3	8.1	10.9	6.4	3.9	24.4	37.1	8.8	1.7	7.4	6.5	16.7	2.6	21.3	11.0	4.1	6.5	7.1	1.6	10.3	20.4	11.4	9.8	2.1	1.9	6.6	5.5	2.8	1.9	4.0	4.1	0.0	9.2	2.9	1.6	3.5	6.3	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.1	2.2	0.0	9.4	10.7	0.0	1.5	7.0	1.1	1.2	0.3	0.0	0.1	0.0	3.1	3.3	0.1	0.0	0.0	0.7	0.0	1.7	0.0	0.1	26.5	3.2	0.3	0.0	7.2	0.0	0.3	0.0	9.1	0.2	0.0	0.0	0.0	5.0	0.6	0.0	0.1	3.2	0.0	0.0	0.0	12.3	1.7	0.0	0.0	2.1	0.0	0.0	11.6	0.0	4.8	5.2	0.3	0.0	1.9	1.8	0.2	0.7	0.1	0.1	0.0	2.3	0.0	2.1	8.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	7.4	8.3	2.7	7.7	6.4	3.9	7.4	6.5	6.5	4.1	20.8	42.8	0.0	7.0	0.8	31.6	19.3	15.3	6.7	5.7	12.2	3.9	1.3	5.0	4.0	33.3	1.0	0.0	0.0	2.6	0.6	4.3	4.4	0.0	47.4	0.6	27.0	0.0	3.1	2.4	6.4	22.2	0.4	0.0	0.0	0.0	19.7	0.2	0.0	22.3	26.7	4.5	6.5	5.7	4.2	0.5	0.1	0.5	0.0	0.0	2.0
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053221-75069483	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		92000	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	8.7	27.4	23.0	13.9	20.4	12.7	16.2	24.0	25.2	10.6	14.9	14.8	14.3	11.3	10.2	26.9	11.6	21.4	7.1	10.8	19.9	30.2	12.2	5.2	10.9	17.6	28.7	19.3	9.1	7.0	8.9	38.2	10.4	24.4	10.0	19.8	9.4	9.7	12.9	22.3	24.4	11.3	11.4	27.5	10.9	14.0	16.7	22.9	8.3	20.2	10.3	19.0	7.5	12.0	10.6	7.6	12.3	6.6	10.0	17.8	5.1	24.8	13.7	19.8	12.1	8.0	9.4	11.0	14.3	5.6	14.6	20.8	13.8	28.1	27.5	8.8	5.9	8.7	22.4	13.0	6.3	23.9	39.9	16.0	17.8	36.1	9.7	4.8	11.2	18.7	5.2	9.1	20.1	10.4	9.4	19.1	26.1	14.0	33.2	19.1	17.0	25.1	20.9	6.0	21.8	13.8	20.2	26.1	12.8	20.5	13.2	36.3	14.7	9.8	6.7	22.2	9.8	14.8	11.1	9.0	10.0	18.5	20.1	15.3	7.9	16.0	28.8	15.3	13.2	10.7	3.9	2.2	12.3	8.6	4.3	9.7	10.0	14.5	9.9	3.8	10.6	12.2	11.3	0.9	10.0	6.6	7.6	17.8	5.1	23.0	20.4	24.0	25.2	19.9	30.2	28.7	19.3	24.4	22.9	6.0	7.8	18.2	36.9	25.4	31.8	17.9	35.7	80.3	19.4	62.8	11.8	19.4	33.2	16.7	18.7	25.1	15.8	70.0	16.2	27.5	20.2	16.2	11.5	4.3	19.1	41.3	28.9	6.7	3.8	7.0	15.5	11.7	37.1	10.0	22.3	16.1	18.0	20.1	15.6	17.3	29.9	25.8	25.8	90.7	15.8	21.0	11.4	22.3	32.3	31.1
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 116.4"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	12.9	24.0	31.0	4.6	33.9	5.6	10.1	15.5	29.3	6.7	6.2	19.4	4.4	6.2	6.7	10.5	6.6	7.1	7.3	39.6	29.1	28.4	8.8	18.7	7.2	7.5	35.7	18.2	5.7	10.3	9.1	9.7	5.9	28.1	10.4	4.8	6.3	11.5	8.4	116.4	6.6	5.6	6.9	35.7	7.8	7.5	6.5	22.7	3.5	8.2	22.9	6.4	8.2	4.1	20.9	23.7	24.1	10.2	12.6	15.9	8.9	7.7	4.3	4.6	3.8	16.8	13.3	4.2	9.3	7.0	5.8	5.1	1.0	5.6	15.1	24.7	9.2	5.8	6.6	2.5	7.8	5.4	13.0	10.3	11.6	4.7	11.5	6.9	9.7	5.6	9.6	14.6	4.1	6.9	11.8	2.6	7.8	4.8	8.1	12.2	4.9	6.0	12.0	5.2	6.1	5.4	4.8	4.4	8.5	13.6	7.1	13.3	8.8	11.3	7.1	4.2	1.8	2.6	8.9	9.3	8.2	7.9	3.6	8.6	17.1	9.4	8.4	11.9	16.6	9.0	24.1	10.2	19.8	13.4	9.0	11.9	20.9	13.4	12.7	14.7	19.7	15.9	13.4	8.5	12.6	8.8	23.7	11.6	8.9	31.0	33.9	15.5	29.3	29.1	28.4	35.7	18.2	28.1	22.7	14.9	13.2	27.4	34.8	18.2	14.8	159.9	25.5	25.4	21.6	17.4	9.8	12.0	53.0	19.2	60.2	23.2	19.1	23.3	33.4	5.0	14.9	30.3	19.6	58.0	27.9	27.0	29.4	26.4	35.8	48.4	12.4	30.9	21.9	21.6	25.3	53.2	29.4	17.5	29.0	36.5	28.8	51.8	26.4	19.2	9.7	18.6	8.6	17.0	18.0	35.7
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
ADPGK	"ADP-GK, DKFZp434B195"	ENSG00000159322	"ADP dependent glucokinase"	Q9BRR6	15	72751369-72785846	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045194, HPA058525"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		35000	Centrosome		"HPA045194: AB_10964638, HPA058525: AB_2683742"	"unprognostic (5.96e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.22e-4)"	"prognostic unfavorable (4.52e-7)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-2)"	15.3	13.5	6.7	16.4	10.7	23.1	13.2	7.8	11.7	10.2	11.3	14.9	11.2	8.9	9.5	14.3	11.1	11.0	12.0	9.3	7.0	9.0	13.3	12.8	18.7	19.8	11.7	6.3	10.7	15.2	4.9	9.1	18.2	13.4	14.2	13.7	20.4	15.8	9.8	7.5	10.9	13.1	8.9	9.8	21.4	10.5	10.7	8.8	19.6	12.0	7.8	21.2	12.3	9.6	14.2	32.0	22.2	30.3	13.8	13.0	22.6	6.8	14.3	7.6	9.0	17.3	13.2	10.3	19.9	19.5	20.9	29.1	8.0	18.0	12.9	14.9	12.4	20.8	18.6	21.6	10.4	15.7	12.7	14.7	9.6	4.2	7.5	11.1	22.1	14.4	14.3	6.1	11.0	10.3	10.3	12.1	10.1	10.1	22.1	12.6	4.3	6.8	9.9	11.4	13.6	6.7	8.1	12.4	17.8	10.8	8.0	5.5	5.7	18.2	7.5	9.6	12.5	7.2	26.8	9.9	10.5	8.8	39.7	18.0	22.4	42.7	12.8	18.4	21.8	17.4	22.2	30.3	21.9	10.6	21.0	13.0	14.2	9.7	10.7	32.0	12.5	8.5	9.8	12.0	13.8	17.1	24.4	7.6	22.6	6.7	10.7	7.8	11.7	7.0	9.0	11.7	6.3	13.4	8.8	17.9	33.0	73.1	17.0	13.6	17.9	2.6	2.5	14.7	19.4	19.2	13.7	33.6	6.6	23.4	12.1	17.9	13.2	0.0	15.4	50.9	22.6	31.3	48.4	22.2	72.8	14.3	7.5	17.8	79.5	4.2	20.1	63.6	25.3	143.3	15.2	12.9	19.0	19.8	14.5	10.3	26.6	19.4	12.2	16.8	25.8	15.8	34.9	34.6	19.3	21.9
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Group enriched"	"Detected in some"	13284	"Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Approved	Cytosol		NA	NA		1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavorable (5.79e-5)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.8	104.7	31.5	101.2	48.3	55.1	100.7	84.1	87.6	85.8	107.3	74.0	107.1	94.7	137.9	84.8	47.1	106.1	63.2	183.3	63.0	41.6	83.1	77.5	84.0	163.3	75.5	112.6	83.2	75.5	64.7	96.3	64.7	141.5	63.1	44.7	66.6	62.5	90.9	198.0	68.4	93.0	78.4	54.0	88.3	102.2	50.6	211.6	106.8	79.1	63.1	44.4	52.4	221.3	78.4	41.1	94.1	76.4	75.0	126.7	50.6	69.1	90.9	123.6	84.3	86.6	235.7	109.4	100.0	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	1628.0	0.0	0.0	0.0	0.0	0.0	1088.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1710.3	0.0	0.0	0.0	0.0	1077.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1138.4	0.0	0.0	0.0
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 1558.3"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA004177	Uncertain		Approved	Cytosol		NA	NA		1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.8	8.9	1.9	6.2	1.5	5.2	1.5	4.1	7.0	5.5	21.8	3.6	5.1	24.7	6.0	6.8	1.8	6.4	14.1	11.1	3.8	4.4	8.0	6.0	8.3	6.0	11.6	10.6	2.3	5.1	0.5	10.8	12.4	4.5	7.8	4.0	1.2	7.2	13.5	3.9	5.0	8.1	2.1	1.7	5.6	7.7	4.0	22.7	15.3	0.7	6.2	5.1	1.0	1.7	1.5	0.6	5.2	4.0	1.7	8.1	2.5	3.7	5.4	7.4	5.5	8.1	7.7	11.5	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5											11.9	25.9	269.9	530.0	703.6	362.0	0.0	315.9	36.1	40.9	40.1	111.9	0.0	94.5	100.6	190.1	242.7	1558.3	46.7	66.6	0.0	38.0	448.8	200.0	94.7	0.0	692.8	311.1	289.1	683.7	930.6	352.7	289.5	877.3	70.3	597.6	553.3	106.3	971.1	380.8	45.3	219.0	478.6	664.3	23.8	81.3	598.3	0.0	258.9	731.1	912.8
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 2651.5;Proximal tubular cells: 6429.5"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA002198, CAB020827"	Enhanced					NA	NA		930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.4	0.0	3.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.5	0.2	0.4	0.0	0.2	3.1	15.6	0.0	0.0	2.6	13.5	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.4	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	48.6	0.0	0.0	1.0	0.9	448.4	0.0	0.0	143.1	0.0	0.0	525.6	3.8	0.0	0.0	62.6	46.7	221.2	0.0	0.0	0.0	0.0	2651.5	0.2	3.2	0.0	50.3	57.0	0.0	0.0	0.0	0.0	6.4	2.6	0.4	297.3	28.8	0.0	6429.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.5	0.0
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.5	0.5	3.5	14.7	7.4	7.6	0.7	3.9	8.8	3.0	18.5	4.4	0.7	3.5	4.6	3.4	0.8	9.9	2.4	24.1	5.6	3.1	2.3	6.8	2.8	7.5	6.9	2.5	8.0	7.0	3.4	0.3	6.0	0.4	1.3	7.3	4.6	19.1	2.6	3.6	2.9	8.3	5.5	1.6	3.9	2.4	0.4	63.4	0.4	1.0	9.4	16.7	2.2	18.1	0.1	5.8	9.8	5.6	0.9	0.3	1.4	0.5	0.6	43.8	12.5	2.6	28.6	7.1	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4	0.0	12.0	9.3	17.7	6.6	72.2	19.0	5.1	0.0	7.9	7.0	100.1	1.2	3.3	14.2	0.8	8.4	22.7	0.0	8.9	3.9	7.1	4.4	12.7	50.8	4.4	259.0	20.7	16.5	4.7	0.8	8.6	3.7	23.6	58.7	8.7	81.4	11.6	14.0	9.6	1.6	259.1	12.9	17.6	0.4	3.2	9.5	1.3	17.0	3.3	8.0
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Group enriched"	"Detected in all"	5	"Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.0;RT4: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA		69000000	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favorable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favorable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.5	5.5	7.4	9.9	8.5	5.0	7.4	13.7	16.6	5.3	8.0	2.2	6.1	5.5	4.1	7.6	10.6	3.7	7.8	7.5	9.4	38.0	6.8	3.2	5.1	2.5	5.8	6.0	4.2	4.9	6.9	10.0	5.5	8.2	19.3	7.0	9.2	7.0	12.6	2.2	9.8	8.4	7.6	9.3	5.3	7.5	5.3	4.0	12.1	61.1	6.3	10.7	6.3	7.7	6.8	8.2	5.1	3.9	14.7	8.5	2.0	11.4	11.1	11.5	13.2	6.9	14.7	5.8	14.5	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8	8.9	26.7	14.4	18.4	34.7	20.3	20.5	15.3	29.4	14.8	26.2	2.0	35.3	109.5	38.4	2.2	11.9	5.1	303.7	15.9	28.0	17.1	21.1	24.3	4.3	13.3	19.1	12.6	8.0	7.3	5.1	9.5	11.3	21.9	19.8	3.8	18.6	36.1	3.5	11.3	47.1	11.6	6.5	24.7	27.9	22.5	11.5	308.5	21.5	4.5	13.7
C21orf2	"A2, LRRC76, YF5"	ENSG00000160226	"Chromosome 21 open reading frame 2"	O43822	21	44328944-44339402	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, DNA damage"		"Ciliopathy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA030283, HPA030284, CAB034126, CAB034128"	Supported		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700"	"unprognostic (1.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (2.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.06e-1)"	18.8	13.4	19.8	11.3	21.6	19.7	9.2	10.3	23.4	13.8	14.7	18.2	14.3	13.4	12.6	19.1	6.9	14.7	13.2	11.3	19.5	16.6	18.0	11.6	12.8	12.4	16.4	19.1	15.2	14.5	7.4	17.6	12.4	13.2	12.3	3.9	14.3	16.1	17.2	21.0	22.3	15.4	5.8	12.6	16.1	21.1	16.7	11.2	10.9	16.4	8.1	13.0	8.1	7.0	10.8	21.7	1.2	8.5	12.1	9.7	4.9	8.0	3.4	3.2	4.2	2.1	1.4	12.9	4.2	2.5	1.7	0.9	6.1	2.4	5.8	8.4	1.4	3.4	3.8	0.6	0.8	0.4	8.8	8.4	6.0	2.7	7.1	2.8	6.5	6.5	2.0	1.5	0.7	1.5	2.9	1.0	4.4	7.3	10.0	1.0	9.9	7.1	15.9	8.1	4.1	5.2	18.1	4.2	12.9	1.9	11.8	8.6	7.9	5.8	1.4	6.9	2.0	6.2	14.3	4.7	3.6	4.7	3.9	3.1	16.3	8.6	4.0	8.9	13.1	6.5	1.2	7.1	1.0	7.1	8.5	8.5	10.8	7.3	9.7	7.3	8.6	8.5	8.2	0.9	12.1	6.2	21.7	4.0	4.9	19.8	21.6	10.3	22.4	19.5	16.6	16.4	19.1	13.2	11.2	3.0	16.5	25.0	18.4	14.4	43.7	2.2	35.7	32.1	9.1	12.2	35.3	25.4	66.3	24.9	73.3	10.0	27.6	0.0	51.4	12.3	38.1	21.2	19.5	18.1	31.3	35.0	31.6	9.2	14.5	196.9	24.5	17.6	40.5	31.5	29.6	34.1	20.6	31.1	29.7	36.0	24.8	12.9	18.9	40.3	10.9	13.6	27.3	20.8	31.8	18.6
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 350.4;Hepatocytes: 400.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 76.4;THP-1: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.2	6.9	5.1	8.0	49.2	21.4	10.8	8.0	10.1	8.9	9.8	3.9	6.3	15.4	7.7	15.7	13.2	14.9	8.5	8.6	9.9	13.5	7.8	13.0	7.4	22.2	5.8	76.4	6.5	11.5	6.0	2.7	1.1	12.6	10.8	9.4	26.9	6.4	11.2	5.9	15.6	13.6	0.0	29.4	16.8	11.1	24.2	12.6	24.5	23.7	2.6	4.1	8.9	14.4	11.8	0.0	20.7	63.8	7.6	5.4	5.2	13.4	4.7	5.2	2.9	3.3	10.6	52.6	3.9	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6	211.4	229.6	40.9	69.6	25.6	11.8	38.0	73.9	89.7	77.3	69.8	25.5	60.5	190.6	26.7	2.1	31.6	91.9	350.4	23.0	26.6	50.3	53.0	22.1	400.0	121.0	0.0	46.1	49.7	114.9	3.8	72.5	85.2	25.3	295.8	48.0	21.2	16.4	52.6	72.9	233.4	17.7	77.6	65.1	4.1	9.6	23.7	33.9	35.5	72.9	69.8
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 38.2;Club cells: 23.9;Melanocytes: 21.9"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"	"Group enriched"	"Detected in some"	20	"HEL: 14.5;RT4: 4.9;SK-BR-3: 11.0;T-47d: 5.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		390000000			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	11.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	38.2	2.7	23.9	3.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
DLAT	"DLTA, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112024814-112064390	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 55.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 95.8;Distal tubular cells: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favorable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	14.1	10.7	10.6	8.8	11.9	4.8	10.9	10.5	14.2	6.7	13.3	6.3	7.8	12.4	6.3	8.1	12.2	7.2	6.4	55.4	10.4	13.5	19.1	12.0	6.6	8.7	11.2	9.7	7.9	6.0	15.8	7.8	8.3	13.0	8.3	13.5	7.6	10.4	9.9	41.0	7.2	13.0	6.6	7.3	6.9	8.1	7.3	4.2	12.7	10.7	22.1	8.8	7.5	6.7	9.2	9.1	7.9	8.9	7.2	10.3	8.0	6.1	6.2	8.3	11.0	11.6	8.7	9.9	8.5	4.9	9.4	10.7	19.7	18.2	25.3	16.7	7.7	12.8	13.3	17.2	9.1	10.7	9.1	10.8	16.1	6.6	12.1	8.3	20.3	9.2	10.5	10.0	9.4	9.5	7.2	8.5	12.5	26.2	12.1	11.0	4.8	9.2	24.3	9.7	15.8	12.1	14.3	11.2	28.5	17.2	6.5	15.9	9.7	10.2	28.9	6.4	9.9	21.4	12.6	5.7	9.4	10.2	9.4	10.9	4.0	6.3	38.4	2.6	22.2	7.3	7.9	6.6	4.7	8.3	8.9	9.5	9.2	8.2	8.9	9.1	7.5	10.3	8.3	0.5	7.2	8.9	7.4	8.8	8.0	10.6	11.9	10.5	14.2	10.4	13.5	11.2	9.7	13.0	4.2	11.9	12.6	16.4	7.1	10.0	7.6	95.8	12.7	32.1	7.9	10.4	0.0	17.8	63.0	16.0	3.0	8.3	19.1	0.0	10.1	34.1	8.5	6.3	3.5	14.3	16.4	7.9	16.6	5.5	12.3	2.3	5.8	7.9	16.9	18.0	18.5	8.6	12.5	3.5	10.3	29.2	10.5	0.0	11.3	21.6	15.8	8.5	14.5	8.6	24.8	9.1
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA		16000000	Mitochondria	Nucleoplasm	"HPA044849: AB_2679111"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favorable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	40.1	32.6	18.1	31.1	26.0	23.0	20.5	23.1	19.5	26.9	20.9	38.0	22.6	39.3	39.9	24.5	44.0	26.7	36.3	32.6	40.7	26.2	21.6	27.6	43.2	27.1	20.0	45.4	28.5	26.2	23.7	28.6	15.6	17.1	32.3	33.0	68.9	29.3	29.2	45.1	37.1	32.9	21.5	48.5	23.7	26.8	29.0	53.3	36.8	60.0	22.5	23.8	37.8	64.0	34.0	37.6	24.4	38.9	20.4	29.8	24.4	57.9	35.1	22.2	42.3	26.4	28.0	48.5	30.7	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7	26.8	16.5	23.1	30.6	27.8	45.9	284.8	61.1	37.5	18.2	75.0	21.6	94.8	192.3	59.5	3.8	30.0	47.9	46.7	49.3	49.9	26.3	23.6	26.5	77.8	61.0	20.6	29.4	27.6	36.8	5.6	21.6	34.1	35.4	65.9	39.3	31.3	37.7	56.1	39.6	134.4	33.4	25.8	43.4	41.2	52.4	28.2	90.6	27.7	64.6	28.5
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 2408.5;Muller glia cells: 2654.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	182.3	159.4	76.9	65.8	64.4	71.9	69.7	99.1	109.9	213.7	200.9	102.1	105.9	131.5	132.4	119.3	87.5	90.0	130.6	264.6	218.0	89.7	138.0	111.0	161.9	126.7	96.7	221.2	68.4	74.2	80.3	169.2	257.3	161.8	136.8	67.1	121.6	51.4	138.5	90.3	83.4	118.4	83.9	65.5	160.0	86.4	114.6	214.7	252.9	43.5	104.0	64.2	116.3	169.4	122.3	96.7	84.8	66.3	125.1	148.0	131.1	126.2	168.6	146.8	104.1	199.5	229.8	181.4	124.2	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8	259.1	414.8	250.1	443.8	370.0	168.1	63.1	310.8	202.1	440.2	575.7	66.8	1020.4	784.2	1640.5	217.6	199.3	508.9	23.3	1210.7	1855.9	354.5	232.4	289.9	288.6	1045.8	456.1	181.6	141.8	389.1	532.9	158.8	475.7	425.1	2408.5	221.4	2654.1	1226.2	336.6	126.9	717.5	187.6	148.8	217.3	150.6	148.2	305.6	837.7	297.2	410.6	403.0
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 94.8;U-87 MG: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	12.2	7.7	2.8	0.1	4.2	4.5	0.2	9.5	6.1	14.1	21.7	1.4	1.0	17.2	1.5	4.1	18.6	1.8	29.3	2.6	21.4	34.4	2.7	23.8	7.9	10.3	3.0	1.3	28.6	2.3	0.1	10.4	2.1	94.8	2.9	22.5	1.5	0.2	9.4	1.6	11.1	1.5	14.9	5.3	4.4	12.4	2.3	3.8	6.9	1.6	22.5	15.8	2.5	0.1	16.2	14.3	0.7	0.7	3.7	12.3	13.0	16.6	12.2	12.6	12.6	2.5	70.7	0.0	2.5	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3	32.8	30.1	5.4	2.3	5.6	242.1	12.0	0.0	21.4	10.3	12.2	294.5	0.2	0.0	16.0	0.3	7.1	0.0	0.0	1.5	0.3	6.6	1.7	65.8	0.0	1.7	405.2	23.0	6.2	0.0	0.0	5.2	2.5	11.8	5.4	0.0	91.6	10.4	0.2	9.2	0.0	613.6	12.9	21.7	1.8	1.3	1.9	0.2	11.4	0.4	1.6
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 511.6;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.9	6.3	2.9	2.7	2.5	0.7	6.9	5.1	0.7	0.3	0.3	3.0	2.0	5.4	7.0	0.4	0.9	3.7	1.0	0.4	0.3	71.7	5.8	5.2	30.7	4.5	0.9	1.6	30.3	4.2	1.0	0.5	1.0	2.6	0.3	6.2	2.4	9.9	1.5	1.6	1.9	6.3	3.7	0.8	2.6	8.5	49.3	25.8	0.7	1.9	1.8	6.9	3.3	2.8	3.7	2.0	2.6	1.7	1.6	3.0	5.7	1.3	3.8	7.0	3.9	4.4	1.7	5.1	3.0	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.0	2.6	2.9	1.0	1.8	3.2	511.6	0.0	0.0	2.3	5.2	3.9	4.3	0.0	1.4	1.3	2.2	4.3	0.0	0.7	3.1	3.6	1.0	8.1	38.1	4.4	3.2	0.0	3.1	3.8	2.7	0.3	4.5	1.7	134.3	2.3	1.5	1.3	1.7	0.4	5.4	2.4	6.5	0.9	8.6	3.9	1.6	2.7	4.3	2.1	0.6
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 322.6;Proximal tubular cells: 631.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	64.2	0.0	1.1	0.2	10.4	2.3	0.0	0.2	0.4	0.0	42.1	0.2	1.2	0.1	12.3	0.0	0.2	7.3	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.2	30.5	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8	71.5	142.5	10.2	6.5	0.7	0.0	0.6	107.0	13.4	68.2	59.3	0.0	9.7	94.5	14.4	0.0	1.8	32.6	23.3	56.4	1.6	1.7	17.4	45.2	322.6	187.5	0.0	30.7	11.1	49.8	0.8	1.4	103.2	11.8	0.0	49.9	2.1	23.8	68.4	3.9	631.0	0.0	6.5	1.2	0.6	0.1	0.9	8.5	13.1	59.5	51.2
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell type enhanced"	"Detected in some"	29	"Exocrine glandular cells: 1.2;Spermatogonia: 3.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.1	0.0	0.0	0.1	0.0	3.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	5.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	4.9	1.1	0.0	0.2	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0
G6PC	"G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42913369	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 305.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 125.4"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052324	Enhanced					NA	NA					"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.0	0.0	5.8	0.1	0.0	0.1	0.1	1.9	0.1	0.1	0.1	23.7	305.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	33.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.5	1.1	0.2	0.5	0.4	0.0	0.4	0.2	0.2	0.5	0.6	0.0	0.7	0.2	0.2	0.0	0.1	0.2	0.3	0.7	0.2	0.3	0.2	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.5	0.8	0.0	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.5	0.7	0.0	0.1	0.5	1.2	0.3	0.0	0.3	0.6	2.2	0.2	0.1	0.7	0.4	0.6	0.7	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.7	0.2	1.0	0.3	1.4	0.2	1.1	0.2	0.1	0.3	0.1	0.2	1.0	0.2	0.2	0.0	2.2	0.4	0.4	1.1	0.5	0.1	0.5	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	22.9	0.0	0.0	1.8	0.0	0.0	1.7	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	125.4	0.1	0.0	0.0	3.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
G6PC2	IGRP	ENSG00000152254	"Glucose-6-phosphatase catalytic subunit 2"	Q9NQR9	2	168901240-168910000	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	35	"pancreas: 28.8;retina: 12.1"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 70.6"	"Cancer enriched"	"Detected in single"	92	"pancreatic cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;SCLC-21H: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (6.42e-2)"				"unprognostic (2.39e-2)"		"unprognostic (6.04e-2)"		"unprognostic (9.05e-2)"		"unprognostic (2.97e-1)"		"unprognostic (3.10e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	70.6	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	25.4	38.1	25.8	15.6	25.4	11.1	23.4	12.9	35.3	25.3	17.8	37.8	28.3	21.1	22.0	50.9	14.4	27.7	20.5	22.2	25.4	37.8	42.8	15.3	18.7	29.8	32.9	21.3	28.1	29.1	38.4	37.7	22.2	34.0	26.1	15.2	37.4	27.7	33.8	22.9	9.9	17.7	17.8	33.1	19.7	18.2	20.7	16.0	18.5	35.1	11.4	14.8	21.4	14.0	5.9	33.4	3.1	19.0	7.2	6.1	6.5	10.2	61.3	21.4	34.5	22.8	17.0	15.1	11.7	24.2	27.6	18.5	25.3	16.6	23.6	17.0	26.2	19.0	17.7	16.3	25.1	13.2	12.1	25.2	13.0	41.5	46.1	23.7	11.6	16.4	22.3	12.1	26.1	18.4	16.8	22.8	10.1	13.3	30.1	20.6	28.6	5.7	18.0	26.8	13.4	39.9	11.9	13.4	54.7	37.4	24.1	25.8	22.8	13.0	15.6	15.0	25.3	43.0	11.8	22.8	27.3	14.5	7.3	16.3	20.1	14.3	6.7	30.4	10.2	34.7	1.2	15.2	3.1	4.6	19.0	5.6	5.5	3.6	4.4	24.6	5.9	4.6	6.1	0.5	7.2	11.1	33.4	3.5	6.5	25.8	25.4	12.9	35.3	25.4	37.8	32.9	21.3	34.0	16.0	3.0	11.7	11.1	13.2	2.3	9.0	5.9	15.3	16.0	13.6	38.4	11.8	55.8	11.6	46.4	3.3	15.6	15.1	0.0	43.1	32.6	15.4	16.0	17.4	5.0	51.3	4.8	22.1	18.4	20.6	4.0	18.7	18.3	13.5	22.6	12.2	34.1	31.2	14.0	21.5	29.3	7.9	12.9	8.6	27.2	28.1	2.3	35.6	8.2	16.9	12.9
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38665910-38741237	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 54.2"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 102.0;Proximal tubular cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.2;T-cells: 29.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.8;U-266/70: 31.3"	"Low region specificity"	"Detected in all"							"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		570000	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	11.2	54.2	3.1	10.4	2.5	0.7	4.6	1.9	2.7	5.9	28.4	2.5	44.3	22.7	6.8	11.8	3.4	11.6	13.3	7.7	2.5	1.8	39.1	28.8	5.8	6.4	2.4	1.9	6.4	7.9	10.4	2.4	3.1	2.9	8.1	10.7	15.3	7.9	29.1	4.6	2.2	39.8	5.4	3.3	4.1	5.0	4.7	2.1	6.4	7.4	3.3	9.3	6.5	5.2	2.8	4.5	13.2	2.1	2.3	29.7	5.3	0.0	10.6	3.3	0.0	11.1	6.5	5.9	1.3	4.0	3.0	4.9	11.9	5.6	4.1	7.9	5.9	6.0	1.7	4.6	0.3	6.0	18.7	7.7	2.2	2.9	23.7	4.0	0.9	0.1	4.5	0.1	6.8	0.0	4.2	3.4	0.0	6.3	27.8	5.5	0.3	9.1	14.8	5.0	22.6	3.5	5.7	0.2	8.0	3.9	18.4	0.6	4.7	0.0	7.6	5.4	4.4	3.6	2.1	1.3	1.0	0.2	7.3	0.4	31.3	21.1	0.1	6.9	2.6	0.1	13.2	2.1	1.8	10.2	1.5	15.0	2.8	16.0	14.8	4.5	2.5	5.8	5.0	5.1	2.3	0.2	0.4	29.7	5.3	3.1	2.5	1.9	2.7	2.5	1.8	2.4	1.9	2.9	2.1	26.8	11.2	12.5	6.5	6.0	2.9	17.3	22.9	24.1	9.1	66.3	0.0	17.0	21.6	9.1	0.8	9.3	102.0	0.0	13.3	25.1	14.3	6.4	6.9	40.4	91.8	3.2	12.7	6.2	12.3	0.5	18.7	36.1	16.9	12.6	36.5	34.6	10.1	63.0	91.9	198.6	7.1	6.5	9.6	1.0	2.1	5.3	5.3	24.5	72.8	4.7
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	188.4	332.6	95.9	149.5	93.6	154.4	209.1	143.2	204.0	209.6	218.8	234.7	129.4	220.4	28.3	168.8	159.1	107.3	89.1	332.2	145.5	193.2	96.8	121.9	208.7	199.3	126.2	197.0	98.1	129.1	108.5	206.0	232.8	501.3	230.7	161.2	65.4	46.4	238.1	376.0	224.4	103.7	354.5	226.1	110.8	182.6	170.9	104.9	238.5	230.6	68.0	109.1	126.4	329.8	190.3	285.1	51.5	139.2	143.9	163.6	197.8	84.4	247.4	105.5	76.7	284.0	346.8	124.9	256.0	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9	220.3	245.0	821.1	1485.4	1615.7	992.1	33.2	1355.4	275.7	444.7	970.1	392.7	4082.4	2934.5	4447.1	583.7	1564.4	2836.9	443.9	3299.5	7140.5	1484.6	1124.2	551.6	1346.2	3470.6	2218.3	1273.2	1144.2	2599.6	1556.8	823.5	2367.4	4003.5	3613.2	2061.2	5234.8	4742.6	2687.7	965.3	5345.0	1026.0	1131.8	2133.1	429.6	390.5	1399.2	3925.6	1271.1	3009.6	2464.1
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6946.0"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.5	16.5	4.6	6.9	0.0	0.0	3.9	1.3	0.0	0.0	0.0	10.0	7.6	7.5	2.2	0.0	1.9	5.5	0.0	0.0	0.0	7.3	8.0	5.0	10.5	5.1	0.1	4.5	6.0	0.0	0.0	0.0	0.0	2.9	0.0	7.3	12.0	4.4	0.0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0.0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6.0	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1712.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	6946.0	23.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	25.8	0.2	30.4	13.5	0.1	0.0	0.0	0.0	0.0
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.3	2.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7	0.0	0.0	0.0	0.7	1.0	5.5	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.9	0.3	0.0	0.6	0.6	4.8	2.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.0	0.1	0.0	2.1	0.0	0.8	0.0	4.3	0.2	0.9	0.1	0.7	0.0	0.0	0.1
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		7600000	Mitochondria		"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	12.7	5.5	19.6	12.4	21.4	11.4	15.2	23.1	16.3	10.9	17.6	8.8	8.1	13.7	9.1	5.0	23.1	18.4	8.6	6.2	18.7	12.7	7.7	3.4	11.4	9.0	11.3	11.8	9.0	7.4	26.6	11.0	7.9	10.3	10.8	17.8	6.8	21.5	7.5	21.2	12.0	24.9	5.9	9.4	10.6	17.1	9.5	8.3	6.7	11.8	17.6	14.0	10.1	10.5	0.5	5.1	3.1	6.5	0.7	0.9	2.7	17.5	11.3	7.1	10.7	14.9	19.0	0.0	22.5	13.8	14.4	17.3	22.2	16.1	3.1	14.6	11.7	5.9	20.2	13.0	20.1	18.4	10.8	4.6	2.6	20.6	0.0	5.2	4.8	5.9	9.0	6.4	24.8	12.4	9.1	10.9	1.6	5.5	0.8	18.0	10.3	0.1	0.4	12.7	6.6	15.0	5.5	4.5	4.1	16.9	22.0	12.6	4.5	20.0	15.1	13.1	11.9	5.1	12.6	10.6	2.8	12.0	12.2	15.8	0.6	0.1	0.1	15.5	1.3	21.5	0.6	6.5	3.1	0.5	3.3	0.9	0.3	0.3	0.9	5.1	0.5	0.7	0.5	2.3	0.7	4.3	0.5	0.9	2.7	19.6	21.4	23.1	16.3	18.7	12.7	11.3	11.8	10.3	8.3	17.9	10.5	5.1	17.9	17.7	4.3	11.3	10.2	10.7	10.3	21.0	5.9	7.0	1.7	8.3	81.5	8.4	22.3	0.0	11.6	12.6	7.8	44.4	12.7	1.8	19.2	4.8	16.7	11.6	14.5	75.7	11.2	13.3	23.6	6.4	14.3	4.3	13.0	20.4	6.7	3.4	9.5	0.0	5.7	1.6	2.0	18.7	9.3	6.9	16.6	62.5
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277583-155289848	"Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved					NA	NA					"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (6.93e-4)"	1.6	3.5	4.5	2.0	7.5	1.5	2.1	20.3	9.5	3.6	4.4	3.3	3.6	7.7	4.5	2.1	3.9	2.2	3.0	1.6	4.0	8.2	4.4	10.2	1.9	2.3	4.1	8.5	4.7	4.7	6.4	12.6	2.4	9.5	2.7	5.0	4.0	4.4	3.6	1.1	9.2	6.6	2.8	3.0	1.9	3.2	1.7	2.1	1.6	2.6	1.3	3.0	2.3	3.6	0.3	0.0	0.0	0.1	0.0	0.6	0.0	1.6	1.8	7.9	3.2	1.3	1.5	1.9	1.3	1.2	1.6	1.9	2.8	5.5	1.5	1.1	1.0	3.4	6.9	2.2	1.0	0.9	2.1	2.8	0.6	5.1	1.8	0.5	0.6	1.6	0.9	1.0	1.1	0.2	1.8	0.3	2.5	3.7	4.4	1.9	2.2	1.1	0.6	2.7	4.2	2.1	3.9	1.9	2.9	2.2	1.7	6.5	4.6	1.2	1.6	0.5	1.5	2.8	1.3	0.1	1.9	1.7	4.0	1.2	1.4	0.6	1.3	1.5	1.1	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.5	20.3	9.5	4.0	8.2	4.1	8.5	9.5	2.1	0.0	1.1	0.0	0.6	1.1	2.4	0.8	2.5	0.0	1.2	1.8	3.9	0.3	0.0	0.9	0.1	0.0	4.6	0.0	0.3	0.3	1.3	0.8	1.1	1.5	0.7	0.0	4.1	3.1	0.0	0.4	0.9	1.3	0.0	1.0	2.3	1.4	0.9	2.9	1.1	0.8	1.8	0.0	0.3	1.5	2.1	2.4	0.0	0.5	3.8	0.9
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.7	10.1	13.6	12.9	15.2	11.4	8.6	17.7	46.6	23.7	25.7	2.9	2.0	1.3	14.0	29.7	17.2	15.6	12.7	39.6	22.7	11.8	9.9	44.2	10.8	0.2	17.3	0.8	33.5	17.2	23.1	33.9	75.8	29.8	24.6	6.6	73.7	9.3	32.4	29.5	5.1	2.2	20.8	9.1	45.1	7.8	8.3	0.1	16.4	21.0	13.9	16.4	20.2	39.4	11.7	20.1	21.5	2.9	25.2	35.5	16.2	19.5	24.7	11.3	7.4	3.1	46.0	23.3	10.2	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6	23.8	29.6	15.8	44.3	42.8	67.3	110.0	7.6	32.1	31.8	26.2	51.1	51.0	11.6	26.4	307.9	34.4	10.3	23.3	26.9	78.8	26.0	25.9	22.0	0.8	45.7	287.6	18.0	25.8	31.3	870.1	14.1	40.6	35.4	24.4	21.8	29.7	36.4	11.5	17.3	0.7	85.2	19.4	42.8	4.3	4.4	45.2	99.4	25.4	12.6	42.9
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74833981-74893359	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 26.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	27.0	2.2	4.4	9.5	5.0	20.4	10.8	0.7	4.5	5.3	23.2	7.3	5.7	1.3	2.6	40.1	13.6	4.8	9.1	8.3	2.8	2.3	2.1	1.4	16.5	5.0	8.5	1.1	14.9	3.5	1.1	1.7	13.2	5.4	4.0	19.2	9.6	10.3	0.5	29.3	9.7	8.9	1.7	10.9	7.4	8.7	24.8	7.4	4.3	7.1	22.3	9.2	29.0	8.3	0.8	6.2	26.2	7.1	0.0	0.8	2.0	16.5	0.1	3.8	14.0	32.9	3.4	14.3	6.4	9.4	7.3	10.5	13.2	3.0	12.0	6.2	3.0	9.4	5.7	17.5	13.6	21.2	3.4	3.7	16.3	3.8	18.2	10.4	23.8	26.9	5.8	14.8	13.8	24.3	8.2	3.4	6.9	14.2	0.0	2.1	11.8	5.7	24.4	13.9	15.7	11.5	9.3	8.1	9.3	4.4	23.4	2.8	13.7	4.1	20.9	8.2	5.8	1.1	3.8	2.8	23.3	4.1	9.6	11.7	8.3	2.3	6.0	54.3	17.5	6.0	6.6	7.1	26.2	0.1	5.7	0.3	0.6	0.4	0.1	6.2	0.8	0.7	0.7	5.9	0.0	3.7	0.1	0.8	2.0	4.4	5.0	0.7	4.5	2.8	2.3	8.5	1.1	5.4	7.4	14.9	37.6	2.9	5.5	45.8	6.2	6.0	7.6	0.0	6.8	5.2	78.5	0.7	0.0	4.4	87.9	3.6	116.3	0.0	3.8	12.3	8.5	17.2	21.9	0.0	15.7	20.6	37.5	1.3	14.6	32.5	13.6	18.9	21.9	1.0	32.2	4.3	18.4	86.0	7.4	0.0	43.3	12.9	2.3	3.1	4.5	49.8	6.9	2.2	19.9	69.9
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Group enriched"	"Detected in some"	13	"Hofbauer cells: 32.3;Kupffer cells: 47.9;Macrophages: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2	0.0	1.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	32.3	0.0	0.0	0.6	47.9	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479600	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HL-60: 15.6"															NA	NA						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.4	0.6	1.4	0.2	2.4	1.9	0.1	0.2	0.4	0.0	0.9	0.2	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.4	0.2	0.2	0.6	0.3	0.7	0.7	0.4	0.0	0.4	0.2	2.2	0.2	0.1	1.9	0.3	0.3	0.2	1.5	0.8	0.0	0.3	0.4	0.4	18.9	0.0	0.1	0.8	0.0	0.1	0.2	0.2	1.3	0.7	3.5	0.5	1.6	1.9	0.2	0.2	0.4	1.0	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.5	0.9	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.7	1.0	0.6	0.9	0.5	0.0	15.6	0.7	0.1	0.3	0.0	0.2	0.2	0.0	1.0	0.4	1.2	0.1	0.3	0.4	1.1	0.4	0.2	0.7	0.8	0.4	1.5	0.1	1.1	0.6	0.5	0.5	0.3	0.2	0.5	0.4	2.2	0.8	0.6	0.2	1.0	0.3	2.7	0.6	0.2	0.3	0.6	0.3	2.1	0.4	0.4	1.9	0.3	0.3	0.9	0.5	0.5	0.7	1.3	1.1	1.0	3.5	1.6	0.5	0.5	1.3	0.2	0.6	0.6	2.4	1.9	0.4	0.5	0.3	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.6	0.0	0.0	4.6	3.6	0.0	0.2	0.0	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206823-59208515	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 56.6"	"Cell type enriched"	"Detected in some"	20	"Spermatocytes: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4"	"Region enriched"	"Detected in single"	6	"olfactory region: 1.7"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.4	0.8	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	103.7	0.6	0.0	0.0	0.0	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		780000000	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.6	87.5	77.0	50.6	55.2	61.5	89.5	45.6	45.6	63.8	63.2	138.5	0.1	115.5	29.9	30.7	62.2	16.4	105.9	84.5	81.3	29.6	73.7	118.8	83.7	0.1	52.8	110.9	51.4	70.3	30.3	55.9	76.1	75.5	72.7	83.7	64.9	17.4	70.1	0.1	94.2	134.3	222.1	53.5	38.0	85.1	107.5	93.1	316.6	145.6	24.8	57.4	20.9	32.5	78.6	213.4	0.2	87.0	28.3	43.0	56.4	30.5	85.8	15.4	20.8	151.7	47.6	53.2	51.0	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6	131.0	259.8	264.1	356.5	64.9	144.4	2212.6	252.3	329.2	235.4	450.1	64.8	1548.4	2801.9	8.8	8.2	201.1	10.6	163.5	278.5	675.2	313.9	183.2	261.1	6.8	514.5	133.5	88.8	124.0	155.9	19.6	254.3	185.3	170.4	154.1	114.8	173.5	149.2	14.4	390.3	2766.7	85.3	232.8	418.6	17.7	95.7	56.1	1371.1	274.1	316.8	307.0
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412307-18452058	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 143.9"	"Group enriched"	"Detected in some"	11	"Early spermatids: 838.5;Spermatocytes: 827.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 3.5;U-2197: 8.7;U-266/70: 7.8;U-266/84: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045442	Enhanced					NA	NA					"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.1	0.7	0.0	0.9	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	143.9	0.3	0.0	0.2	0.1	0.2	0.0	0.0	2.4	2.7	3.6	1.1	0.2	3.8	1.2	0.0	0.0	0.3	2.0	1.5	1.6	2.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.2	2.8	0.2	1.1	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.2	1.0	0.2	0.1	0.6	0.0	0.4	0.2	0.5	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.9	0.0	2.2	3.5	0.5	0.1	0.2	0.1	0.9	0.4	2.8	8.7	0.1	7.8	6.8	0.3	0.1	0.0	0.1	1.3	0.7	1.0	0.6	1.0	2.3	0.8	1.8	2.2	0.0	2.4	3.8	2.6	3.6	0.2	1.1	2.7	1.7	1.2	0.7	0.9	0.6	0.4	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	1.4	1.2	1.8	0.0	0.0	3.3	0.3	838.5	0.6	0.0	0.0	5.5	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.0	78.1	21.6	0.0	0.0	0.0	0.0	1.0	1.2	0.0	17.0	2.9	0.6	19.4	0.0	827.5	26.0	0.5	0.0	0.0	0.0	0.1
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA family member 3, ER export factor"	Q5JRA6	1	222618086-222668012	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA055922, HPA056816"	Supported		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		750000	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	20.5	24.1	21.4	17.4	23.7	25.8	25.0	32.8	25.0	23.3	19.3	10.0	26.2	18.7	23.5	24.4	15.7	18.1	18.5	19.5	18.4	17.4	19.5	63.7	18.4	19.0	17.0	18.8	23.4	34.1	30.2	34.7	22.7	25.6	30.1	23.1	9.9	32.8	31.7	25.5	16.5	23.2	21.3	22.9	23.0	36.6	29.3	19.6	19.5	25.6	19.5	19.3	26.8	19.8	18.6	14.9	29.4	20.1	22.0	18.3	11.1	11.7	8.9	13.9	21.1	44.1	22.2	23.3	16.9	25.3	18.7	22.3	9.2	12.2	9.7	16.1	19.1	11.3	20.1	14.8	15.6	19.2	16.6	9.2	13.3	9.2	14.4	40.5	22.8	16.1	20.3	15.0	17.9	31.7	21.9	19.6	14.6	17.0	23.7	14.1	7.1	17.8	14.7	15.3	36.8	12.8	12.1	37.7	23.3	9.6	11.7	15.0	15.8	17.4	15.8	14.0	20.4	16.9	15.0	14.2	12.7	9.8	21.4	17.9	27.1	17.2	12.1	15.9	11.0	16.6	23.6	14.6	29.4	17.4	19.5	18.3	18.3	15.0	17.0	10.4	18.6	17.8	17.4	24.8	22.0	20.1	14.9	16.0	11.1	21.4	23.7	32.8	25.0	18.4	17.4	17.0	18.8	25.6	19.6	65.5	44.7	27.0	22.7	16.7	55.5	55.8	28.1	60.2	58.0	5.2	29.5	23.4	0.0	21.4	25.4	21.9	30.2	23.3	30.0	14.2	25.4	40.1	16.3	52.3	18.5	42.9	58.0	17.8	17.4	18.1	34.2	23.7	18.6	13.6	83.2	42.1	26.6	22.0	46.0	21.6	37.6	19.4	25.6	49.2	40.6	14.1	30.0	34.1	22.9	26.0
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 422.4;Distal tubular cells: 300.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		15000	Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favorable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.6	31.9	23.1	24.3	22.4	17.2	28.4	17.7	15.8	36.7	28.4	45.4	16.5	43.8	13.2	21.3	49.1	33.5	70.9	30.7	38.7	14.5	39.5	21.7	54.9	39.9	23.8	34.7	17.8	22.1	28.6	33.8	33.6	18.6	22.3	27.4	19.1	18.6	25.6	33.9	28.9	35.6	23.5	47.1	55.8	29.9	38.8	53.6	63.2	26.2	12.8	13.6	28.2	35.8	32.0	52.0	37.7	24.4	13.8	19.0	17.1	51.6	22.4	15.8	16.2	29.0	17.9	24.3	16.4	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0	41.7	37.7	36.5	48.9	26.6	58.2	422.4	79.0	26.8	50.0	144.8	31.4	91.3	300.1	74.7	2.0	28.6	76.1	23.3	52.1	102.6	45.2	31.9	42.6	65.5	65.3	23.8	40.3	16.0	21.0	2.9	32.8	35.5	54.0	51.3	52.9	37.8	43.3	57.5	38.2	164.1	60.9	32.3	48.4	17.4	13.0	29.2	111.6	30.9	97.8	51.0
PDHA2	PDHAL	ENSG00000163114	"Pyruvate dehydrogenase E1 alpha 2 subunit"	P29803	4	95840019-95841474	"Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	146	"testis: 60.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 311.1;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	311.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	45.9	1.6	0.0	0.0	0.0	0.0	0.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.3	24.1	30.2	35.7	36.8	48.2	18.5	40.8	13.6	30.5	33.1	11.1	33.7	22.1	27.3	23.6	24.8	36.4	50.5	36.3	28.6	29.5	20.5	30.3	20.5	28.7	16.9	41.9	30.7	34.1	18.7	18.4	38.7	18.2	27.9	31.0	38.2	20.2	30.4	13.3	21.6	39.3	56.3	26.2	19.3	21.2	22.3	32.2	24.0	41.8	47.6	31.7	22.5	19.1	25.5	20.0	27.2	25.8	36.6	28.7	29.3	35.1	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5	56.6	28.0	47.4	32.8	24.7	30.0	245.7	48.4	69.6	48.9	33.2	23.6	144.4	195.6	84.1	43.2	62.9	34.8	23.3	63.6	85.4	31.9	17.8	38.1	61.1	74.4	54.0	55.7	43.6	38.0	10.4	55.8	41.0	54.0	89.2	44.3	51.8	51.0	41.3	48.1	105.9	44.7	64.7	61.8	85.0	80.3	26.1	131.5	46.0	47.8	28.8
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 117.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	13.5	14.9	13.4	8.6	17.2	4.2	10.4	13.9	23.3	9.2	13.3	10.6	9.3	12.2	8.9	8.6	10.9	6.7	7.7	46.1	14.4	12.8	15.0	25.7	7.8	6.8	14.7	14.1	7.7	13.1	14.6	14.7	15.8	22.1	12.0	12.7	8.9	12.4	14.1	70.5	8.8	12.3	11.5	12.0	6.6	13.7	15.7	9.0	5.9	9.1	19.0	8.7	13.0	10.7	12.8	19.5	12.1	21.7	15.0	14.9	9.8	9.1	24.0	13.9	5.5	10.2	12.1	13.6	17.1	14.0	19.4	18.9	31.0	8.5	12.6	11.2	14.4	22.7	17.8	26.9	14.4	19.3	11.3	22.5	11.8	25.3	35.6	22.2	22.3	14.0	12.3	17.9	10.6	14.5	11.2	14.0	10.8	25.3	11.6	15.2	15.6	13.8	13.8	11.3	25.2	14.4	12.1	24.9	10.9	29.0	24.1	14.7	10.7	15.1	22.9	23.4	14.5	25.7	13.8	9.7	14.4	16.2	14.8	18.9	11.1	22.0	15.6	11.3	11.0	14.5	8.6	13.6	12.1	11.5	15.0	10.8	12.8	10.9	9.4	19.5	11.7	13.3	9.6	2.8	15.0	21.7	5.2	14.9	9.8	13.4	17.2	13.9	23.3	14.4	12.8	14.7	14.1	22.1	9.0	32.8	21.1	9.0	18.1	23.1	25.5	117.0	20.4	18.7	19.4	5.2	27.5	53.6	54.7	18.3	35.0	10.9	12.8	23.3	12.6	28.3	19.4	19.1	5.7	22.1	23.1	19.1	8.6	9.8	15.0	31.1	10.0	15.5	20.3	28.9	16.0	18.1	13.9	14.4	12.7	22.7	23.2	0.0	20.9	40.9	33.4	22.2	69.5	10.4	19.0	16.9
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1800000	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.6	14.3	10.2	29.4	16.1	12.0	45.0	24.6	16.0	14.3	14.1	19.2	7.2	19.4	29.3	16.4	13.7	17.8	8.1	22.3	3.3	16.3	18.4	39.2	12.5	31.3	12.4	29.5	25.0	15.7	13.6	14.6	7.2	21.7	21.0	14.2	24.1	22.2	9.7	41.5	12.7	23.0	16.0	29.3	16.1	31.5	9.7	52.6	6.5	36.2	18.0	13.5	35.8	30.4	15.7	4.3	24.1	26.1	30.4	21.7	14.0	14.2	9.4	43.2	11.7	7.9	36.1	23.5	17.3	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1	20.8	27.5	37.6	33.4	31.7	71.1	12.6	17.8	21.4	28.4	87.2	62.8	106.3	84.6	68.0	1.8	43.0	285.1	0.0	45.0	147.2	44.6	37.8	41.5	60.1	95.6	28.6	44.5	41.1	58.5	5.2	36.2	60.1	65.8	177.7	107.9	59.6	51.1	112.2	52.3	108.3	44.6	25.8	42.9	1.4	8.7	31.6	134.4	31.9	139.6	44.5
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.5	27.5	20.0	5.5	23.7	21.8	20.5	14.5	21.0	11.0	52.1	19.6	11.4	12.0	9.7	23.3	23.9	19.3	1.2	12.2	14.8	19.3	0.6	14.7	0.7	8.6	28.3	14.1	18.0	29.7	34.3	23.2	0.8	17.8	26.3	18.8	6.6	18.3	1.2	19.2	9.6	26.5	30.8	15.7	40.0	14.0	9.7	31.9	23.5	14.0	22.2	23.7	22.4	22.5	3.2	20.9	9.5	13.1	13.9	19.7	14.4	38.3	28.5	18.4	1.5	7.9	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8	14.9	5.9	6.8	17.7	6.5	38.0	326.0	17.8	9.4	7.9	21.0	41.2	2.2	56.3	9.4	29.7	15.8	2.2	0.0	2.2	3.5	16.7	6.1	1.1	2.5	3.5	114.4	8.7	9.8	2.7	19.6	28.4	3.2	52.3	18.0	6.2	114.5	3.3	0.0	44.9	25.8	41.0	25.8	26.2	46.8	11.5	4.5	2.1	4.4	12.1	7.6
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 368.5;Late spermatids: 396.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.8	67.3	4.5	0.1	4.5	9.5	58.8	29.8	10.7	30.2	36.4	70.9	50.9	5.7	23.8	21.4	28.0	38.9	23.0	46.5	31.8	16.1	17.7	20.7	32.4	3.8	10.7	8.3	34.8	4.4	10.5	31.7	15.8	45.8	58.1	24.3	5.7	0.2	33.4	37.4	28.3	9.0	7.4	21.0	23.6	22.2	7.5	23.1	32.7	18.8	12.4	10.7	21.1	18.0	26.4	56.5	14.8	13.1	69.9	20.6	11.1	62.1	32.4	32.7	29.5	20.5	52.9	16.0	12.6	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8	3.0	6.5	16.7	44.9	25.4	38.3	113.1	10.2	21.4	27.3	61.1	51.1	2.1	36.5	101.2	368.5	28.8	46.6	0.0	9.2	171.9	17.4	35.9	56.4	0.8	28.5	39.7	35.7	14.1	12.6	396.4	6.9	16.2	18.6	21.6	19.5	104.9	80.1	28.1	6.3	2.1	105.7	12.9	30.8	39.9	3.2	19.7	22.2	27.3	24.5	48.7
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426160-97433441	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 698.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		200000000	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	26.5	46.1	42.8	28.9	50.3	30.2	19.0	32.6	90.0	26.5	27.6	24.9	14.2	29.8	24.3	20.6	63.5	17.7	21.2	54.1	47.4	44.9	32.7	35.7	18.5	29.5	45.7	61.1	22.9	14.3	27.8	23.2	30.8	72.4	21.9	29.2	30.4	24.5	33.7	8.4	30.0	27.4	35.6	25.7	21.7	20.3	26.1	21.0	26.6	17.4	27.0	43.7	31.0	31.9	22.5	49.7	88.0	65.3	22.8	41.2	72.8	119.7	57.0	39.4	75.1	37.3	34.4	53.7	76.8	100.5	90.3	126.0	61.8	35.8	63.5	52.7	65.2	36.3	75.2	68.4	111.7	109.5	58.7	65.4	41.0	44.7	69.1	27.6	58.7	54.9	33.6	45.8	60.0	44.8	122.3	65.3	47.7	26.8	36.0	94.7	49.5	52.4	72.5	60.3	34.7	68.4	39.9	36.1	50.3	69.7	45.5	8.6	40.3	41.3	24.7	39.4	64.5	67.2	49.5	49.1	48.4	42.6	42.7	88.1	54.3	59.8	57.9	112.5	98.2	22.3	30.4	65.3	88.0	37.0	57.2	32.7	22.5	31.8	36.6	49.7	18.8	20.7	28.9	50.3	22.8	62.8	17.6	41.2	72.8	42.8	50.3	32.6	90.0	47.4	44.9	45.7	61.1	72.4	21.0	41.7	37.7	99.1	98.5	166.1	402.1	21.4	81.5	34.8	53.4	101.2	72.6	433.1	303.4	278.9	11.6	112.3	222.3	46.7	180.1	698.3	148.4	67.2	102.6	165.4	366.0	365.5	46.3	103.7	173.5	17.6	138.4	127.2	124.9	317.4	104.7	280.3	240.1	115.6	220.3	200.3	232.1	200.5	123.6	31.0	121.7	178.9	311.6	142.2	136.4	230.0
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Group enriched"	"Detected in many"	13	"Early spermatids: 421.0;Late spermatids: 1332.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.3	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1	0.0	0.0	0.5	0.2	1.0	4.3	0.0	0.0	0.0	0.0	0.0	9.8	0.0	68.0	0.0	421.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.0	0.0	0.3	1332.7	7.2	0.4	1.7	0.0	0.0	3.8	0.2	0.2	5.6	1.9	4.2	25.8	3.1	30.5	5.6	0.5	0.0	0.0	0.2	0.4
PGAM4	"dJ1000K24.1, PGAM-B, PGAM1, PGAM3"	ENSG00000226784	"Phosphoglycerate mutase family member 4"	Q8N0Y7	X	77968874-77969638	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 2.1;Melanocytes: 3.3;Suprabasal keratinocytes: 2.0"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 5.4"									"HPA042528, HPA060483"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"unprognostic (3.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-3)"	0.9	2.1	0.9	2.6	1.5	3.0	0.4	0.8	2.1	1.9	0.6			2.4	1.4	0.7	2.9	1.3	0.0	1.3	1.0	1.5	0.9	1.2	0.4	1.2	1.5		1.0	0.1	0.7	0.7	0.7		0.5	0.7		0.6	0.2	1.1	0.8	2.0	1.3	0.4	1.0	1.3	0.5			0.3		0.7	1.6	1.2	0.7	1.9	3.7	2.4	0.8	1.6	3.5	5.4	3.1	0.3	0.9	0.4	0.0	2.7	0.5	0.1	0.6	0.8	0.0	0.5	0.8	1.5	0.3	0.0	2.3	0.2	0.0	0.8	0.6	0.3	0.0	1.1	0.7	0.0	1.6	0.9	0.4	0.2	0.2	0.0	0.1	0.5	0.3	0.0	0.6	0.8	1.0	2.7	3.9	1.1	0.3	0.8	0.8	1.0	2.0	0.0	0.7	0.1	2.7	0.3	0.0	1.3	0.3	1.0	0.6	0.0	1.0	1.8	1.6	3.1	2.8	1.4	0.7	3.7	1.6	0.5	0.6	2.4	3.7	1.4	2.2	1.1	0.7	1.1	1.3	1.9	0.7	0.6	0.9	1.5	0.8	2.1	0.5	1.6	3.5											0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129296	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					NA	NA		290000000			"CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"	"prognostic unfavorable (7.05e-8)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.65e-6)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	45.0	50.9	29.2	41.3	38.4	62.2	29.9	43.8	67.9	31.9	36.6	24.2	27.5	35.5	25.7	23.3	62.1	25.6	32.4	69.4	28.6	35.0	71.8	58.5	37.5	47.6	32.1	32.7	26.8	21.2	45.7	29.0	43.7	49.9	28.3	42.8	40.0	38.2	32.0	115.5	38.7	41.9	33.9	30.1	43.7	29.7	11.3	24.9	51.8	39.1	61.1	52.4	42.2	38.0	20.9	53.7	49.2	79.0	21.0	26.3	77.0	100.7	46.7	15.6	31.6	27.1	22.0	37.3	51.6	35.9	45.4	76.2	42.3	31.8	40.4	53.5	35.6	54.1	43.9	69.2	80.2	91.1	24.6	27.3	31.3	77.1	36.7	29.7	71.5	34.9	27.4	33.9	41.2	21.9	73.2	46.4	39.9	32.6	61.8	61.9	39.8	62.5	54.1	48.4	68.0	89.0	45.3	42.0	123.7	47.3	42.1	23.4	32.3	53.4	45.6	44.8	41.6	23.9	37.6	37.3	48.6	33.6	48.5	35.5	68.7	128.4	42.4	137.0	81.5	31.7	22.7	54.6	49.2	20.8	59.9	23.2	20.9	25.0	22.6	53.7	15.8	23.0	24.4	45.7	21.0	79.0	20.9	26.3	77.0	29.2	38.4	43.8	67.9	28.6	35.0	32.1	32.7	49.9	24.9	140.0	160.9	145.9	244.9	128.1	204.1	404.2	163.1	85.6	114.9	165.7	72.6	242.5	399.6	557.2	11.8	143.5	182.6	46.7	207.9	529.0	138.1	108.8	187.4	169.3	452.6	292.4	98.3	141.2	307.1	7.6	87.8	291.4	158.6	539.2	123.3	226.5	430.4	133.6	119.5	437.4	139.8	122.9	131.3	8.4	51.9	104.1	292.3	207.0	146.6	230.5
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785651-49787307	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"testis: 70.2"	"Group enriched"	"Detected in some"	48	"Early spermatids: 906.2;Late spermatids: 2050.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.0;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported					NA	NA					"HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	906.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2050.3	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	6.5	0.0	30.9	8.6	0.0	0.0	0.0	0.0	0.0
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 209.3;Hepatocytes: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		NA	NA		20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	29.8	12.5	4.7	15.5	31.2	23.1	38.3	12.3	16.7	13.4	22.0	10.3	13.9	9.4	25.8	19.0	29.7	7.1	6.5	25.9	15.8	11.5	8.7	19.9	21.2	10.6	25.8	17.4	1.1	29.1	16.7	15.6	24.8	36.0	8.0	9.8	0.0	12.6	21.5	1.8	5.0	9.6	21.4	0.9	20.1	7.1	22.0	3.0	19.5	9.4	2.8	18.4	26.9	28.2	41.0	22.9	8.8	6.6	0.7	19.9	10.2	17.6	10.4	8.0	11.7	15.4	32.5	15.3	8.5	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5	86.4	31.4	19.9	24.0	15.9	8.1	140.8	50.9	14.7	10.3	15.7	9.8	71.5	74.6	42.0	24.0	10.7	74.3	0.0	209.3	136.9	28.0	18.3	4.7	186.6	22.2	0.0	12.6	16.0	18.3	5.2	20.4	10.7	25.3	32.5	40.1	54.2	92.3	23.0	35.7	59.8	10.7	12.9	17.9	4.7	7.5	15.8	49.2	21.8	71.1	13.6
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12.0	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17.0	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10.0	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9	0.0	8.0	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0.0	26.6	5.0	13.0	0.8	25.5	7.9	0.0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5.0	52.3	9.0	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 123.0"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		NA	NA		380000	Cytosol		"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758"	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	5.9	13.6	0.8	7.5	1.3	0.0	4.1	2.1	1.5	25.9	52.2	1.8	26.1	2.9	36.9	10.3	22.6	20.9	11.1	31.6	1.0	0.4	2.0	1.5	2.7	5.9	0.9	1.3	9.3	1.9	0.5	1.2	1.7	1.3	37.1	7.6	4.3	2.9	51.1	8.5	2.2	15.4	123.0	1.5	1.7	16.6	4.3	0.9	0.9	2.8	4.5	1.5	57.4	24.5	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	4.2	3.4	2.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	29.8	0.0	20.7	0.9	0.9	0.0	0.0	0.1	0.0	25.9	1.4	0.6	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.8	1.3	2.1	1.5	1.0	0.4	0.9	1.3	1.3	0.9	0.0	1.7	0.0	5.1	2.1	22.3	88.7	0.0	1.4	3.4	12.2	3.9	0.0	1.7	0.1	1.2	35.0	0.0	0.0	0.0	0.1	3.3	2.7	0.0	0.0	0.1	0.0	0.0	31.9	3.2	0.0	7.5	1.9	3.3	1.8	0.0	8.4	0.1	0.0	4.6	0.6	1.1	51.8	36.4	0.1	0.2	2.0	0.0	0.0	0.0	1.3
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"K-562: 48.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA		2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Cell type enhanced"	"Detected in all"	5	"monocytes: 1878.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.9	210.9	42.5	50.3	51.2	57.5	35.1	88.9	207.7	142.9	144.6	59.3	101.0	62.4	90.0	166.4	106.4	119.5	134.4	181.0	112.0	109.5	63.5	38.2	106.1	49.1	35.6	49.5	82.5	52.2	84.3	110.0	45.2	185.5	84.1	32.1	9.5	50.1	225.2	50.9	18.5	21.3	52.6	125.8	80.5	55.0	136.1	118.9	189.6	105.5	44.2	48.3	116.0	71.6	90.9	74.7	50.2	36.1	65.4	162.8	89.0	159.0	161.3	64.4	90.9	55.0	200.4	82.0	159.4	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4	110.2	78.1	134.8	464.1	502.3	450.3	279.7	94.3	129.8	157.0	786.9	347.5	523.8	679.8	1147.1	307.8	224.6	361.4	70.0	528.2	1096.0	273.6	329.6	203.1	2.0	698.2	1005.9	270.8	71.2	307.3	1333.1	145.6	439.7	337.4	1878.3	130.3	624.4	887.7	231.5	252.1	165.5	510.0	122.9	245.6	32.6	84.3	340.0	481.5	163.0	247.6	730.1
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 48.3;OE19: 57.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061992			Approved	Vesicles		NA	NA			Vesicles		"HPA061992: AB_2684652"	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	3.2	3.3	16.1	21.5	10.7	0.0	8.5	2.7	10.6	10.0	70.0	8.2	7.0	37.9	8.5	9.4	28.8	5.0	24.2	4.5	9.7	9.4	11.4	4.4	7.2	2.4	10.9	5.7	6.2	12.4	9.0	4.7	47.3	6.8	14.7	37.4	7.4	11.8	8.4	1.9	26.9	76.7	7.3	7.3	3.1	35.0	3.7	6.0	1.1	23.6	16.9	14.2	12.5	15.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	29.9	8.1	0.0	7.8	14.9	9.0	29.3	4.4	7.2	10.7	13.8	20.2	48.3	0.0	13.1	5.9	13.6	18.4	7.0	25.9	3.2	34.8	1.4	0.0	2.9	1.0	10.8	0.1	0.4	7.7	23.7	16.3	4.5	7.2	4.7	3.1	4.1	0.0	5.5	32.1	0.0	0.6	2.5	57.6	14.1	4.0	12.2	0.1	3.9	38.5	0.4	4.0	3.1	20.1	10.1	5.0	21.8	5.8	8.9	10.5	11.2	23.5	9.4	1.1	2.5	3.5	7.5	0.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	10.7	2.7	10.6	9.7	9.4	10.9	5.7	6.8	6.0	17.9	25.1	9.7	74.9	18.1	5.9	2.8	76.5	6.7	6.8	45.4	3.9	34.8	23.2	128.9	43.4	11.3	673.9	0.0	180.9	127.1	10.8	130.2	5.7	1.5	7.4	0.0	58.3	12.9	1.8	20.3	18.4	3.7	13.5	5.4	310.3	13.7	137.0	422.1	23.0	38.7	8.7	6.5	11.3	11.1	8.9	55.7	53.8	0.0	231.5	148.6
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	115.0	103.1	54.7	84.5	53.6	56.6	96.6	83.3	92.0	157.5	191.0	106.5	63.3	67.6	16.8	82.2	81.5	57.3	130.0	139.2	174.7	89.1	96.8	87.5	75.6	70.2	39.9	99.6	71.9	61.4	58.1	121.4	104.7	221.1	95.7	34.4	45.2	26.0	120.8	84.7	52.3	84.2	134.8	98.1	65.8	30.7	90.0	69.3	98.6	82.2	38.9	64.8	72.7	75.6	40.3	119.8	17.3	74.9	59.1	84.5	72.3	54.6	122.1	50.8	20.8	100.9	169.5	62.0	60.6	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4	125.0	186.6	268.1	429.8	608.3	247.2	505.0	410.2	145.9	159.3	369.9	104.1	935.0	1278.3	1116.4	147.7	369.6	973.7	70.0	686.0	1611.5	538.5	310.9	357.6	425.4	827.4	281.3	408.6	284.8	382.5	523.4	258.3	552.8	639.4	1545.5	419.4	603.3	953.1	852.2	247.5	1236.2	208.3	194.1	473.8	15.1	66.8	538.4	1279.9	363.9	717.3	571.4
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.2	11.1	5.3	5.1	17.2	15.4	5.1	10.0	14.1	13.3	12.9	4.6	2.6	2.8	5.6	11.8	11.6	14.3	4.7	10.3	15.3	8.3	6.3	4.1	5.2	5.1	7.7	6.3	6.2	10.6	11.0	6.5	9.3	9.5	12.4	0.2	3.1	2.8	16.9	6.9	0.2	2.1	1.4	14.2	11.5	1.0	12.2	3.5	16.0	14.6	2.2	4.7	11.0	14.1	8.8	6.8	11.2	3.8	9.3	12.3	6.5	20.4	9.8	0.6	6.3	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0	14.9	17.1	0.8	5.1	5.6	8.9	8.5	2.5	21.4	13.6	22.7	9.8	7.4	3.3	9.2	2.3	7.1	18.7	0.0	11.4	6.2	6.9	7.6	5.8	13.0	10.8	14.3	8.7	12.9	15.3	1.4	7.5	10.4	6.8	6.4	14.4	12.3	11.0	7.0	17.3	11.4	11.0	12.9	7.5	6.5	5.9	8.2	6.4	6.9	13.0	6.5
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195108-75209348	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	14.1	12.1	15.6	12.5	22.5	12.7	28.1	19.1	24.1	15.5	18.9	10.8	13.6	13.7	12.8	19.0	18.1	13.5	15.7	24.4	17.4	11.3	18.0	23.4	13.3	12.7	12.9	18.4	19.6	19.5	22.4	20.5	26.2	19.3	13.8	21.4	13.5	16.3	14.1	34.5	15.8	24.0	16.9	12.1	15.0	15.5	7.1	11.2	11.2	20.7	15.5	14.5	17.4	15.5	2.7	3.3	12.1	5.2	2.5	4.8	2.3	9.4	6.3	6.7	13.8	10.5	13.6	7.4	17.2	20.0	6.8	8.5	3.8	13.5	6.6	2.8	17.0	8.0	12.9	8.3	14.5	4.8	41.3	12.2	14.9	13.9	7.5	7.5	25.1	15.2	15.0	14.6	5.4	12.5	12.6	13.9	15.8	8.0	24.5	12.9	11.1	6.3	12.4	1.7	9.2	14.4	13.5	10.8	21.9	13.2	16.1	12.5	10.3	9.5	9.8	10.9	5.0	9.8	12.5	12.3	13.4	10.2	4.2	5.4	4.0	17.4	4.5	8.8	21.8	10.7	1.9	5.0	12.1	4.8	4.2	3.8	2.7	4.1	4.5	3.3	2.5	2.3	3.5	2.7	2.5	5.2	2.5	4.4	2.3	15.6	22.5	19.1	24.1	17.4	11.3	12.9	18.4	19.3	11.2	32.8	14.1	10.4	16.0	8.7	56.1	45.6	17.8	5.3	10.3	26.2	5.9	8.2	16.6	10.1	0.4	23.3	27.4	0.0	18.6	5.9	16.9	16.0	6.9	20.7	14.3	23.8	22.5	19.6	18.6	1.1	33.9	14.8	11.8	14.4	25.7	20.9	12.7	21.0	59.4	14.6	39.1	19.4	9.8	0.3	6.3	9.7	5.6	10.0	27.0	18.3
